Andrew Perry

Companies

• G1 Therapeutics, Inc.Chief Commercial Officer Aug 17, 2021 to Sep 18, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• GTG1 Therapeutics, Inc.0 shares²Sep 18, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 18, 2024U 14,232 shares of G1 Therapeutics, Inc.²
• Sep 18, 2024Returned to company 114,482 shares of G1 Therapeutics, Inc.²
• Sep 18, 2024Granted 16,100 shares of G1 Therapeutics, Inc.²
• Jul 5, 2024Sold 1,337 shares at $2.51 of G1 Therapeutics, Inc.³
• Jul 1, 2024Granted 35,000 shares of G1 Therapeutics, Inc.⁴
• May 13, 2024Sold 8,151 shares at $4.79 of G1 Therapeutics, Inc.⁵
• Jan 3, 2024Sold 2,034 shares at $3.12 of G1 Therapeutics, Inc.⁶
• Jan 3, 2024Sold 379 shares at $3.12 of G1 Therapeutics, Inc.⁶
• Jan 3, 2024Granted 33,570 shares of G1 Therapeutics, Inc.⁶
• Jul 5, 2023Sold 355 shares at $2.45 of G1 Therapeutics, Inc.⁷
• May 10, 2023Granted 35,000 shares of G1 Therapeutics, Inc.⁸
• Jan 4, 2023Sold 820 shares at $5.58 of G1 Therapeutics, Inc.⁹
• Jan 3, 2023Granted 16,100 shares of G1 Therapeutics, Inc.⁹
• Jan 3, 2022Granted 6,000 shares of G1 Therapeutics, Inc.¹⁰